Illumina Inc

14 de jul. de 2026, 19:36 UTC

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

10 de jul. de 2026, 20:06 UTC

Illumina Inc shares are lower amid a broader decline in the biotechnology sector. Market volatility is heightened due to geopolitical tensions involving the U.S. and Iran.

9 de jul. de 2026, 19:11 UTC

Illumina Inc. appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, contributing to a rise in shares amid sector gains.

8 de jul. de 2026, 20:04 UTC

Illumina Inc shares are lower today, influenced by declines in the Life Sciences Tools & Services sector and a drop in the Russell 2000 Index.

7 de jul. de 2026, 21:41 UTC

Illumina Inc. shares are higher in after-market trading, reflecting ongoing strength despite earlier session pullbacks and broader caution in the technology sector.

6 de jul. de 2026, 19:52 UTC

Evercore ISI raised its price target on Illumina to $200, maintaining an Outperform rating. Shares are trading higher amid positive sentiment and social media discussions.

2 de jul. de 2026, 23:06 UTC

Illumina Inc shares declined in after-market trading, reflecting broader trends despite positive movements in European equity indices, including a rise in the DAX.

1 de jul. de 2026, 20:03 UTC

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

30 de jun. de 2026, 20:01 UTC

Illumina Inc shares are lower as Roche launches a competing gene sequencer at a lower price, challenging Illumina's market share in genetic testing technology.

29 de jun. de 2026, 23:16 UTC

Illumina Inc shares are lower in after-market trading, with no specific news identified to explain the movement. Broader U.S. equities show mixed performance.

26 de jun. de 2026, 23:16 UTC

Illumina Inc shares are trading lower in after-market hours. Broader market concerns over rising interest rates and inflation may be influencing investor behavior.

25 de jun. de 2026, 23:26 UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

24 de jun. de 2026, 20:02 UTC

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23 de jun. de 2026, 22:46 UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22 de jun. de 2026, 19:32 UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19 de jun. de 2026, 00:02 UTC

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18 de jun. de 2026, 23:01 UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17 de jun. de 2026, 20:03 UTC

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16 de jun. de 2026, 19:56 UTC

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15 de jun. de 2026, 13:02 UTC

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12 de jun. de 2026, 19:56 UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11 de jun. de 2026, 20:03 UTC

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10 de jun. de 2026, 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9 de jun. de 2026, 19:26 UTC

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8 de jun. de 2026, 20:06 UTC

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5 de jun. de 2026, 23:16 UTC

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4 de jun. de 2026, 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3 de jun. de 2026, 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2 de jun. de 2026, 23:21 UTC

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1 de jun. de 2026, 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.